SKK
ELGX

Shepherd Kaplan Krochuk’s Endologix Inc ELGX Stock Holding History

Shepherd Kaplan Krochuk’s Portfolio ELGX Stock Details ELGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-600
Closed -$74K – 459
2015
Q3 		$74K Buy
+600
New +$81.4K 0.02% 346

Other funds holding ELGX

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
CWAM
Columbia Wanger Asset Management Chicago, Illinois $6.69B AUM 31.14% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return

Shepherd Kaplan Krochuk's ELGX Position: Q2 2017 in Review

Shepherd Kaplan Krochuk sold out of Endologix Inc (ELGX) in Q2 2017, closing a stake of 2,983 shares — an estimated $216K sold.

Shepherd Kaplan Krochuk first reported a position in ELGX in Q4 2014 and held it in 10 quarters. The position peaked at $1.09M in Q3 2016. 111 funds tracked by Wall St. Rank hold ELGX as of Q2 2017.

  • Shepherd Kaplan Krochuk reported no remaining Endologix Inc position as of Q2 2017 after selling out during the quarter.
  • Shepherd Kaplan Krochuk sold 2,983 Endologix Inc shares in Q2 2017, an estimated $216K.
  • Shepherd Kaplan Krochuk first reported a position in Endologix Inc in Q4 2014 and held it in 10 quarters.
  • Shepherd Kaplan Krochuk's Endologix Inc position peaked at $1.09M in Q3 2016.
  • 111 funds tracked by Wall St. Rank held Endologix Inc as of Q2 2017.

Based on Shepherd Kaplan Krochuk's 13F filing for Q2 2017, filed 10 Aug 2017.